Stephen Hoge, President at Moderna, Inc. (MRNA), sold 4,776 shares at $94.57 ($452K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Scheduled sale ($452k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.57 | 2,388 | $226K | 50.0% |
| 2 | $94.57 | 2,388 | $226K | 50.0% |
| Total | $94.57 avg | 4,776 | $452K | 100% |
| Filing → |
| MRNA | SELL | 2026-07-16 | $3.6M | — | Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |